Dedic, N.; Dworak, H.; Zeni, C.; Rutigliano, G.; Howes, O.D.
Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies. Int. J. Mol. Sci. 2021, 22, 13185.
https://doi.org/10.3390/ijms222413185
AMA Style
Dedic N, Dworak H, Zeni C, Rutigliano G, Howes OD.
Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies. International Journal of Molecular Sciences. 2021; 22(24):13185.
https://doi.org/10.3390/ijms222413185
Chicago/Turabian Style
Dedic, Nina, Heather Dworak, Courtney Zeni, Grazia Rutigliano, and Oliver D. Howes.
2021. "Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies" International Journal of Molecular Sciences 22, no. 24: 13185.
https://doi.org/10.3390/ijms222413185
APA Style
Dedic, N., Dworak, H., Zeni, C., Rutigliano, G., & Howes, O. D.
(2021). Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies. International Journal of Molecular Sciences, 22(24), 13185.
https://doi.org/10.3390/ijms222413185